UNITED STATES

SECURITIES AND EXCHANGE COMMISSION

Washington, D.C. 20549





FORM 10-KSB





(Mark One)



[ X ]

ANNUAL REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934



For the fiscal period ended March 31, 2003



[     ]

TRANSITION REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934



For the transition period from _____________ to _____________



Commission file number:  ____________







LANWERX ENTERTAINMENT, INC.

(formerly LUNA MEDICAL TECHNOLOGIES, INC.)

_______________________________________________________________________________

(Exact name of registrant as specified in its charter)





|Nevada                                                         | 98-0207745                          
|-------------------------------------------------------------- | ------------------------------------
|(State or other jurisdiction of incorporation or organization) | (I.R.S. Employer Identification No.)







c/o Suite 677, 999 Canada Place, Vancouver, British Columbia, Canada  V6C 3E1

(604) 682-8439

_______________________________________________________________________________

(Address and telephone number of registrants principal executive offices and principal

place of business)





Indicate by check mark whether the registrant: (1) has filed all reports required to be filed by Section 13 or 15(d) of the Securities Exchange Act of 1934 during the preceding 12 months (or for such shorter period that the registrant was required to file such reports), or (2) has been subject to such filing requirements for the past 90 days.



Yes

[ X ]

No

[     ]





The number of outstanding common shares, $ .001 par value, of the Registrant at:



March 31, 2003:  33,095,660





































LANWERX ENTERTAINMENT, INC.



(formerly LUNA MEDICAL TECHNOLOGIES, INC.)



(A Development Stage Company)



FINANCIAL STATEMENTS



AS AT MARCH 31, 2003































------INDEX------







Auditors Report



Statements of Operations



Statements of Stockholders Equity/(Deficit)



Balance Sheets



Cash Flow Statements



Notes to Financial Statements

















































Auditors' Report



To the Shareholders of

LanWerX Entertainment, Inc.

(formerly Luna Medical Technologies, Inc.)





We have audited the balance sheets of LanWerX Entertainment, Inc. (formerly Luna Medical Technologies, Inc) as at March 31, 2003 and 2002 and the statements of operations, changes in stockholders equity/(deficit), and cash flows for the years then ended. These financial statements are the responsibility of the Company's management.  Our responsibility is to express an opinion on these financial statements based on our audit.



We conducted our audits in accordance with generally accepted auditing standards in the United States.  Those standards require that we plan and perform an audit to obtain reasonable assurance whether the financial statements are free of material misstatement.  An audit includes examining, on a test basis, evidence supporting the amounts and disclosures in the financial statements.  An audit also includes assessing the accounting principles used and significant estimates made by management, as well as evaluating the overall financial statement presentation.



In our opinion, these financial statements present fairly in all material respects, the financial position of the Company as at March 31, 2003 and 2002 and the results of its operations and its cash flows for the years then ended in conformity with generally accepted accounting principles in the United States.



The accompanying financial statements referred to above have been prepared assuming that the Company will continue as a going concern.  As discussed in Note 2 to the financial statements, the Company is in the development stage, has no established source of revenue and is dependent on its ability to raise capital from shareholders or other sources to sustain operations.  These factors, along with other matters as set forth in Note 2, raise substantial doubt that the Company will be able to continue as a going concern.  The financial statements do not include any adjustments that might result from the outcome of this uncertainty.











MacKay LLP

Vancouver,  Canada.

Chartered Accountants

September 23, 2003





























LANWERX ENTERTAINMENT, INC.

(Formerly LUNA MEDICAL TECHNOLOGIES, INC.)

(A Development Stage Company)

STATEMENTS OF OPERATIONS

FOR THE YEAR ENDED MARCH 31, 2003 AND 2002



(Stated in US Dollars)



|                                     | March 31
2003        | March 31,
2002  
|------------------------------------ | -------------------- | ----------------
|                                     |                      |                 
|EXPENSES                             |                      |                 
|Management fees                      | $         120,000    | $        42,800 
|Legal                                | 15,144               | 5,761           
|Bank charges and interest            | 13,728               | 11,811          
|Auditing and accounting              | 4,441                | 8,449           
|Transfer agent                       | 2,525                | 2,568           
|Regulatory fees                      | 332                  | -               
|                                     |                      |                 
|                                     | 156,170              | 71,389          
|                                     |                      |                 
|NET LOSS FOR THE YEAR                | $       (156,170)    | $     (71,389)  
|                                     |                      |                 
|NET LOSS PER COMMON SHARE            | $             (0.01) | $         (0.01)
|                                     |                      |                 
|WEIGHTED AVERAGE NUMBER OF BASIC AND |                      |                 
|DILUTED COMMON SHARES OUTSTANDING    | 28,917,578           | 8,095,660       









The accompanying notes are an integral part of these financials statements.































LANWERX ENTERTAINMENT, INC.

(Formerly LUNA MEDICAL TECHNOLOGIES, INC.)

(A Development Stage Company)

STATEMENTS OF STOCKHOLDERS EQUITY/(DEFICIT)

AS AT MARCH 31, 2003



(Stated in US Dollars)





|                                                                   | Common

Number of Shares | Shares


Amount | Additional Paid-In Capital | Share Subscriptions Receivable | Comprehensive Income    | Accumulated Deficit | Total Shareholders Equity/(Deficit)
|------------------------------------------------------------------ | ------------------------ | --------------- | -------------------------- | ------------------------------ | ----------------------- | ------------------- | ------------------------------------
|                                                                   |                          |                 |                            |                                |                         |                     |                                     
|Balance, March 31, 2001                                            | 8,095,660                | $     8,096     | $   434,459                | $                    -         | $                     - | $      (759,459)    | $      (316,904)                    
|                                                                   |                          |                 |                            |                                |                         |                     |                                     
|Net loss for the year ended                                        |                          |                 |                            |                                |                         |                     |                                     
|March 31, 2002                                                     | -                        | -               | -                          | -                              | -                       | (71,389)            | (71,389)                            
|                                                                   |                          |                 |                            |                                |                         |                     |                                     
|Balance, March 31, 2002                                            | 8,095,660                | 8,096           | 434,459                    | -                              | -                       | (830,848)           | (388,293)                           
|                                                                   |                          |                 |                            |                                |                         |                     |                                     
|Issuance of common shares in exchange for debt at $0.005 per share | 25,000,000               | 25,000          | 100,000                    | -                              | -                       | -                   | 125,000                             
|                                                                   |                          |                 |                            |                                |                         |                     |                                     
|Net loss for the year ended                                        |                          |                 |                            |                                |                         |                     |                                     
|March 31, 2003                                                     | -                        | -               | -                          | -                              | -                       | (156,170)           | (156,170)                           
|                                                                   |                          |                 |                            |                                |                         |                     |                                     
|Balance, March 31, 2003                                            | 33,095,660               | $   33,096      | $   534,459                | $                    -         | $                     - | $      (987,018)    | $       (419,463)                   









The accompanying notes are an integral part of these financial statements.































LANWERX ENTERTAINMENT, INC.

(Formerly LUNA MEDICAL TECHNOLOGIES, INC.)

(A Development Stage Company)

BALANCE SHEETS



(Stated in US Dollars)



|                                                                             | March 31
2003          | March 31,
2002   
|---------------------------------------------------------------------------- | ---------------------- | -----------------
|ASSETS                                                                       |                        |                  
|CURRENT ASSETS                                                               |                        |                  
|Prepaid expenses                                                             | $                   -  | $            682 
|                                                                             |                        |                  
|Total Assets                                                                 | $                   -  | $            682 
|                                                                             |                        |                  
|LIABILITIES AND SHAREHOLDERS EQUITY/(DEFICIT)                               |                        |                  
|CURRENT LIABILITIES                                                          |                        |                  
|Accounts payable                                                             | $          60,584      | $       80,926   
|Accrued expenses                                                             | 6,500                  | 7,133            
|Short-term loans                                                             | -                      | 32,704           
|Convertible notes payable (Note 3)                                           | 36,288                 | -                
|Advances from shareholders (Notes 4, 6, and 8)                               | 316,091                | 268,212          
|                                                                             |                        |                  
|Total Liabilities                                                            | 419,463                | 388,975          
|                                                                             |                        |                  
|STOCKHOLDERS EQUITY/(DEFICIT)                                               |                        |                  
|Preferred shares, 5,000,000 shares authorized, $0.001 par value;             |                        |                  
|no shares issued and outstanding (Note 5)                                    |                        |                  
|Common shares, 50,000,000 shares authorized, $0.001 par value;               |                        |                  
|33,095,660 and 8,095,660 shares issued and outstanding respectively (Note 6) | 33,096                 | 8,096            
|Additional paid-in capital                                                   | 534,459                | 434,459          
|Accumulated deficit                                                          | (987,018)              | (830,848)        
|                                                                             |                        |                  
|                                                                             | (419,463)              | (388,293)        
|                                                                             |                        |                  
|Total Liabilities and Stockholders Equity/(Deficit)                         | $                    - | $             682
|                                                                             |                        |                  
|                                                                             |                        |                  
|(Note 10 subsequent events)                                                  |                        |                  







Approved by the directors:





Cameron King

______________________________

Cameron King





Gordon McDougall

______________________________

Gordon McDougall







The accompanying notes are an integral part of these financial statements.

































LANWERX ENTERTAINMENT, INC.

(Formerly LUNA MEDICAL TECHNOLOGIES, INC.)

(A Development Stage Company)

CASH FLOW STATEMENTS

FOR THE YEAR ENDED MARCH 31, 2003 AND 2002



(Stated in US Dollars)



|                                                    | March 31
2003         | March 31,
2002     
|--------------------------------------------------- | --------------------- | -------------------
|                                                    |                       |                    
|OPERATING ACTIVITIES                                |                       |                    
|Net loss for the year                               | $       (156,170)     | $      (71,389)    
|                                                    |                       |                    
|Changes in non-cash working capital items           |                       |                    
|Prepaid expenses                                    | 682                   | (682)              
|Accounts payable                                    | (20,342)              | 8,924              
|                                                    |                       |                    
|Cash provided/(used) by operating activities        | (175,830)             | (63,147)           
|                                                    |                       |                    
|                                                    |                       |                    
|FINANCING ACTIVITIES                                |                       |                    
|Advances from shareholders                          | 172,879               | 63,144             
|Accrued expenses                                    | (633)                 | -                  
|Short-term loans repaid                             | (32,704)              | -                  
|Convertible notes payable issued                    | 36,288                | -                  
|                                                    |                       |                    
|Cash provided/(used) by financing activities        | 175,830               | 63,144             
|                                                    |                       |                    
|CASH INCREASE/(DECREASE)                            | -                     | (3)                
|                                                    |                       |                    
|CASH, BEGINNING OF YEAR                             | -                     | 3                  
|                                                    |                       |                    
|CASH, END OF YEAR                                   | $                   - | $                 -
|                                                    |                       |                    
|SUPPLEMENTAL DISCLOSURE:                            |                       |                    
|Interest paid                                       | $          13,728     | $       11,808     
|Income taxes paid                                   | $                   - | $                - 
|                                                    |                       |                    
|NON-CASH ACTIVITIES:                                | $                   - | $                - 
|Exchanged office equipment for release from payable | $                   - | $                - 
|Loss on disposal of subsidiary                      | $                   - | $                - 
|Issued stock for subscription receivable            | $        125,000      | $                - 
|Issued stock for reduction in debt                  |                       |                    







The accompanying notes are an integral part of these financial statements.



































LANWERX ENTERTAINMENT, INC.

(formerly LUNA MEDICAL TECHNOLOGIES, INC.)

(A Development Stage Company)

NOTES TO FINANCIAL STATEMENTS

FOR THE YEAR ENDED MARCH 31, 2003











1.

ORGANIZATION AND DESCRIPTION OF THE BUSINESS



LanWerX Entertainment, Inc., (formerly Luna Medical Technologies, Inc.), (the Company) was incorporated on January 19, 1999 under the laws of the State of Nevada for the purpose of engaging in any lawful activity.  On May 31, 1999 the Company amended its articles of incorporation to reflect the name change to Luna Medical Technologies, Inc.  On May 19, 2003, the company changed its name to LanWerX Entertainment, Inc..



The financial statements include all activity of the Company.  The Company is seeking a major transaction.



As a result of the change in business (see note 10) cumulative from inception figures have not been presented as management do not consider that these figures would provide meaningful information.



The Company maintains an office in Vancouver, British Columbia.  The Company has elected a fiscal year-end of March 31.







2.

SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES



This summary of significant accounting policies is presented to assist the reader in understanding the Companys financial statements.  The financial statements and notes are a representation of the Companys management which is responsible for their integrity and objectivity.



(i)

Accounting Method



The Companys financial statements are prepared using the accrual method of accounting.



(ii)

Loss Per Share



Basic loss per share was computed by dividing the net loss by the weighted average number of shares outstanding during the year.  The weighted average number of shares was calculated by taking the number of shares outstanding and weighting them by the amount of time that they were outstanding.  Diluted loss per share is the same as basic loss per share, as the inclusion of common stock equivalents would be anti-dilutive.



(iii)

Provision for Taxes



At March 31, 2003, the Company had net operating losses of approximately $979,000 that may be offset against operating income through 2016.  No provision for taxes or tax benefits has been reported in the financial statements as there is not a measurable means of assessing future profits or losses.



(iv)

Use of Estimates



The process of preparing financial statements requires the use of estimates and assumptions regarding certain types of assets, liabilities, revenues, and expenses.  Such estimates primarily relate to unsettled transactions and events as of the date of the financial statements.  Accordingly, upon settlement, actual results may differ from estimated amounts.



(v)

Advertising



Advertising costs are charged to operations in the year incurred.



(vi)

Impairment of Long-Lived Assets



The Company evaluates the recoverability of long-lived assets when events and circumstances indicate that such assets might be impaired.  The Company determines impairment by comparing the undiscounted future cash flows estimated to be generated by these assets to their respective carrying amounts.  At March 31, 2003, there were no long-lived assets.



(vii)

Cash and Cash Equivalents



The Company considers all highly liquid investments with maturity of three months or less at the date of acquisition to be cash equivalents.  At March 31, 2003, there were no cash equivalents.



(viii)

Derivative Instruments



At March 31, 2003, the Company has not engaged in any transactions that would be considered derivative instruments or hedging activities.



(ix)

Compensated Absences



The Company has no employees.  At such time as the Company hires personnel, its employees will be entitled to paid vacation, paid sick days, and personal days off depending on job classification, length of service, and other factors.  The Companys policy will be to recognize the cost of compensated absences when actually paid to employees.



(x)

Foreign Currency Transactions



All figures presented are in US dollars.  Foreign currency transactions are translated to US dollars using the exchange rate in effect at the time of the transaction.



(xi)

Going Concern



The accompanying financial statements have been prepared assuming that the Company will continue as a going concern.  As shown in the accompanying financial statements, the Company incurred a net loss of $156,170 and has negative working capital for the year ended March 31, 2003.  The Company is currently seeking a major transaction, which will, if successful, mitigate these factors which raise substantial doubt about the Companys ability to continue as a going concern.  The financial statements do not include any adjustments relating to the recoverability and classification of recorded assets, or the amounts and classification of liabilities that might be necessary in the event the Company cannot continue in existence.  Management intends to seek additional capital from new debt and equity issuances that will provide funds needed to increase liquidity, fund internal growth, and fully implement its business plan.



(xii)

Fair Value of Financial Instruments



The carrying amounts of payables, and accrued expenses approximate their fair value.







3.

CONVERTIBLE NOTES PAYABLE



There are three convertible notes payable dated June 1, 2002 totalling $30,000 with interest at 2% per month compounded semi-annually, due and payable on May 31, 2003.  The principal and interest is convertible into common shares at a conversion price of $0.01 per share, at the option of the lender, with the conversion price of $0.01 based on the Companys share structure as of June 1, 2002.







4.

ADVANCES FROM SHAREHOLDERS



Advances from shareholders consist of the following at March 31, 2003:



(i)

There was an advance from Campbell Capital Advisory, Inc. totalling $136,760 (March 31, 2002 - $131,864). The amount is unsecured and bears 10% interest per annum.  Campbell Capital Advisory, Inc. is a related company under the control of the Companys former president (see Notes 6 and 8).



(ii)

There is a note payable to Javelin Enterprises totalling $2,536 (March 31, 2002 - $2,297).  The note payable is unsecured, has no stated maturity, and bears 10% interest per annum.  Total interest accrued during the year ended March 31, 2003 was $239.  During December of 1999, the Company issued 80,000 common shares as partial satisfaction of the note.  Javelin Enterprises is a shareholder of the Company (see Note 8).



(iii)

There was an advance from King Capital Corporation totalling $176,795 (March 31, 2002  $133,851).  The amount is unsecured and bears no interest.  King Capital Corporation is a shareholder of the Company (see Notes 6 and 8).







5.

PREFERRED SHARES



The Company is authorized to issue up to 5,000,000 preferred shares with a par value of $0.001 per share.  The preferred shares do not carry any pre-emptive or preferential rights to subscribe to any unissued stock or any other securities which the Company may be authorized to issue and does not carry voting rights.



No preferred shares were issued as of March 31, 2003.







6.

COMMON SHARES



The Company is authorized to issue up to 50,000,000 common shares with a par value of $0.001 per share.  The voting rights of the common shares are non-cumulative.



Upon incorporation, 7,310,660 common shares were sold, 7,170,000 at $0.001 per share and 140,660 at $0.50 per share.



During the year ended March 31, 2000, the Company issued 630,000 common shares for cash at $0.50 per share.  The Company also issued 100,000 common shares in settlement of outstanding debt at $0.50 per share.



During the year ended March 31, 2001, the Company issued 55,000 shares at $0.001 per share for a subscription receivable that was subsequently paid.



During the year ended March 31, 2003, the Company issued 25,000,000 shares at $0.005 per share for a total of $125,000, for a reduction of debt.







7.

WARRANTS AND OPTIONS



The Company issued one warrant with each share of common stock subscribed for during a subscription year in the fall of 1999.  The warrants had an exercise price of $1.00 per share which expired on December 1, 2000.  As of March 31, 2003, no warrants had been exercised and all warrants have expired.



The Company does not have a formal stock option plan; however, the Company issued options to two consultants during the year ended March 31, 2000.  The options had no value due to the fact that the exercise price was in excess of the fair market value on the date of grant.  On May 8, 2000, the Company cancelled this agreement with the required 30 days notice, and the consultants relinquished their claim to these options.







8.

RELATED PARTIES



The former president and chief executive officer of the Company, Gordon C. McDougall, is also the president and shareholder of Campbell Capital Advisory, Inc. (CCA) which had advanced funds to the Company for operations and to retain the services of an attorney.  As of March 31, 2003, the Company owes CCA $136,760. (see Notes 4 and 6).



The Company executed a promissory note in favour of a shareholder for funds advanced to the Company. As partial satisfaction of the note, 80,000 common shares were issued.  As of March 31, 2003, the balance owing on the note was $1,939 plus interest of $597 (see Note 4).



As at March 31, 2003, the Company also received an advance from a corporation owned by a shareholder of the Company totalling $176,795 (see Notes 4 and 6).







9.

FOREIGN OPERATIONS



The accompanying balance sheet includes the Companys assets in Canada.  Although Canada is considered politically and economically stable, it is always possible that unanticipated events in foreign countries could disrupt the Companys operations.







10.

SUBSEQUENT EVENTS



Effective May 1, 2003 Cameron King and Gordon C. McDougall were elected as Directors and Officers of the Company, and Brent Shaw and Bradley Hofstad resigned as Directors and Officers of the Company.



Effective May 19, 2003 the Companys name was changed to LanWerX Entertainment Inc. and the Companys shares were consolidated on the basis of 1 new share for 50 old shares.



The Company is actively seeking merger candidates and has entered into Agreements to acquire Netopia Internet Café of Vancouver, British Columbia, and LiveWire Leisure Ltd (operating as PC Arena) of Clouchester, England.



Netopia is a computer LAN game centre with 50 high-speed computer terminals and each having the latest game software.  Netopia has been operating on the campus of the University of British Columbia in Vancouver, British Columbia, Canada since January 2002.  The terms of the transaction are to acquire all the assets of Netopia for 800,000 common shares of LanWerX Entertainment Inc., with a deemed value of $200,000.  The transaction was completed on September 23, 2003.



LiveWire Leisure Ltd. (PC Arena) operates four locations, one corporate store, and three franchises around the communities of London, England.  The computer LAN centres are operated with 25 to 30 high-speed computer terminals and the latest game playing software.  On the premises of each PC Arena, the principals operate the Computer Store where new and refurbished computer and components are sold.  The Company is now in the final stages of completing the transaction whereby the founders and investors of LiveWire will receive 4,000,0000 common shares of LanWerX Entertainment Inc. and a one time financial payment of US$100,000. The Company is expected to close the transaction on or about September 30, 2003.



































LANWERX ENTERTAINMENT, INC.

(formerly LUNA MEDICAL TECHNOLOGIES, INC.)

(A Development Stage Company)

MANAGEMENT DISCUSSION AND ANALYSIS

FOR THE PERIOD ENDED MARCH 31, 2003







The Company is actively seeking merger candidates and has entered into Agreements to acquire Netopia Internet Café of Vancouver, British Columbia, and LiveWire Leisure Ltd (operating as PC Arena) of Clouchester, England.



Netopia is a computer LAN game centre with 50 high-speed computer terminals and each having the latest game software.  Netopia has been operating on the campus of the University of British Columbia in Vancouver, British Columbia, Canada since January 2002.  The terms of the transaction are to acquire all the assets of Netopia for 800,000 common shares of LanWerX Entertainment Inc., with a deemed value of $200,000.  The transaction was completed on September 23, 2003.



LiveWire Leisure Ltd. (PC Arena) operates four locations, one corporate store, and three franchises around the communities of London, England.  The computer LAN centres are operated with 25 to 30 high-speed computer terminals and the latest game playing software.  On the premises of each PC Arena, the principals operate the Computer Store where new and refurbished computer and components are sold.  The Company is now in the final stages of completing the transaction whereby the founders and investors of LiveWire will receive 4,000,0000 common shares of LanWerX Entertainment Inc. and a one time financial payment of US$100,000. The Company is expected to close the transaction on or about September 30, 2003.



On July 1, 2003 the Company issued 15,000,000 common shares at $0.005 per share for a total of $75,000 for a reduction of debt to related parties.



On August 1, 2003, the Company authorized the issuance of 1,500,000 common shares at  $0.25 per share to consultants to be hired for professional services.



Effective September 24, 2003 the Company changed its name to GameState Entertainment, Inc.







































SIGNATURE



The registrant hereby certifies that it meets all of the requirements for filing on Form 10-QSB and that it has duly caused and authorized the undersigned to sign this Quarterly Report in its behalf.







LUNA MEDICAL TECHNOLOGIES, INC.







By: (Signed) CAMERON KING

Chief Executive Officer







Date:  September 29, 2003